Biaxin and Polymyalgia rheumatica - a phase IV clinical study of FDA data


Polymyalgia rheumatica is found among people who take Biaxin, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Biaxin and have Polymyalgia rheumatica. It is created by eHealthMe based on reports of 13,004 people who have side effects when taking Biaxin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 27, 2022

13,004 people reported to have side effects when taking Biaxin.
Among them, 22 people (0.17%) have Polymyalgia rheumatica.

What is Biaxin?

Biaxin has active ingredients of clarithromycin. It is often used in sinusitis. eHealthMe is studying from 13,642 Biaxin users for its effectiveness, alternative drugs and more.

What is Polymyalgia rheumatica?

Polymyalgia rheumatica (pain in many muscles) is found to be associated with 813 drugs and 457 conditions by eHealthMe.

Number of Biaxin and Polymyalgia rheumatica reports submitted per year:

Could Biaxin cause Polymyalgia rheumatica?

Time on Biaxin when people have Polymyalgia rheumatica *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Polymyalgia rheumatica when taking Biaxin *:

  • female: 90.91 %
  • male: 9.09 %

Age of people who have Polymyalgia rheumatica when taking Biaxin *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 9.52 %
  • 60+: 90.48 %

Common drugs people take besides Biaxin *:

  1. Prednisone: 16 people, 72.73%
  2. Zometa: 14 people, 63.64%
  3. Aredia: 14 people, 63.64%
  4. Femara: 14 people, 63.64%
  5. Dyazide: 14 people, 63.64%
  6. Levaquin: 14 people, 63.64%
  7. Lodine: 14 people, 63.64%
  8. Paxil: 14 people, 63.64%
  9. Ranitidine: 14 people, 63.64%
  10. Peridex: 14 people, 63.64%

Common side effects people have besides Polymyalgia rheumatica *:

  1. Pain: 19 people, 86.36%
  2. Anaemia (lack of blood): 18 people, 81.82%
  3. Stress And Anxiety: 18 people, 81.82%
  4. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 15 people, 68.18%
  5. Oedema Peripheral (superficial swelling): 15 people, 68.18%
  6. Rashes (redness): 15 people, 68.18%
  7. Weight Loss: 14 people, 63.64%
  8. Intestinal Obstruction: 14 people, 63.64%
  9. Osteomyelitis (infection of bone): 14 people, 63.64%
  10. Oral Pain: 14 people, 63.64%

Common conditions people have *:

  1. Breast Cancer: 14 people, 63.64%
  2. Bone Pain: 12 people, 54.55%
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 4.55%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 4.55%
  5. Drowsiness: 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Biaxin and have Polymyalgia rheumatica?

Check whether Polymyalgia rheumatica is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Polymyalgia rheumatica and when was it recovered:

Expand to all the drugs that have ingredients of clarithromycin:

Alternative drugs to, pros and cons of Biaxin:

Common Biaxin side effects:

Browse all side effects of Biaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Polymyalgia rheumatica treatments and more:

COVID vaccines that are related to Polymyalgia rheumatica:

Common drugs associated with Polymyalgia rheumatica:

All the drugs that are associated with Polymyalgia rheumatica:

Common conditions associated with Polymyalgia rheumatica:

All the conditions that are associated with Polymyalgia rheumatica:

How the study uses the data?

The study uses data from the FDA. It is based on clarithromycin (the active ingredients of Biaxin) and Biaxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: